Evidence map›Paper›PMID 27980407›Full record

ArticleInternational journal of nanomedicine

PEG-

Tian Zhou, Qinglei Dong, Yang Shen, Wei Wu, Haide Wu, Xianglin Luo, Xiaoling Liao, Guixue Wang

Abstract read
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Co-Delivery ofFrontiers in pharmacology · 2022
    Article
  3. Article
  4. Nano-Medicine in the Cardiovascular System.Frontiers in pharmacology · 2021
    Review
  5. Article
  6. Dual tumor-targeted poly(lactic-International journal of nanomedicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tian ZhouKey Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing.
Qinglei DongKey Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing.
Yang ShenInstitute of Biomedical Engineering, School of Preclinical and Forensic Medicine, Sichuan University.
Wei WuKey Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing.
Haide WuKey Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing.
Xianglin LuoCollege of Polymer Science and Engineering, Sichuan University, Chengdu, Sichuan.
Xiaoling LiaoChongqing Key Laboratory of Nano/Micro Composite Materials and Devices, School of Metallury and Materials Engineering, Chongqing University of Science and Technology, Chongqing, People's Republic of China.
Guixue WangKey Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro/nanoparticles could cause adverse effects on cardiovascular system and increase the risk for cardiovascular disease-related events. Nanoparticles prepared from poly(ethylene glycol) (PEG)-

Indexed as

AnimalsApoptosisCaproatesDrug CarriersGreen Fluorescent ProteinsHumansHuman Umbilical Vein Endothelial CellsIn Situ Nick-End LabelingLactonesMicellesMicroscopy, FluorescenceNanoparticlesNeovascularization, PathologicPolyestersPolyethylene GlycolsPolymerase Chain ReactionCaproatescaprolactoneDrug CarriersGreen Fluorescent ProteinsLactonesMicellesPolyestersPolyethylene GlycolsTP53 protein, humanTumor Suppressor Protein p53angiogenesisapoptosiscardiovascular diseasesnanoparticlesPEG-b-PCLzebrafish

Identifiers

PMID27980407
PMCPMC5147414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.